HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway

Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR‐targeting agents to treat head and neck squamous cell carcinoma

(2021) Hannah Zaryouh et al.   MEDICINAL RESEARCH REVIEWS

PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma

(2021) Kun Wu et al.   Frontiers in Oncology

MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence

(2021) Marta Gabasa et al.   CANCER LETTERS

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma

(2021) Mohsen Ahmadi et al.   FEBS Open Bio

Hypoxanthine Guanine Phosphoribosyltransferase expression is negatively correlated with immune activity through its regulation of purine synthesis

(2020) Michelle H. Townsend et al.   IMMUNOBIOLOGY

Hypoxanthine Phosphoribosyl Transferase 1 Is Upregulated, Predicts Clinical Outcome and Controls Gene Expression in Breast Cancer

(2020) Melina J. Sedano et al.   Cancers

Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells

(2020) Rania Harati et al.   PLoS One

Potential new biomarkers for endometrial cancer

(2019) Michelle H. Townsend et al.   Cancer Cell International

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

(2016) BO ZHOU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Characterizing and optimizing human anticancer drug targets based on topological properties in the context of biological pathways

(2015) Jian Zhang et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress

(2013) C. Bassi et al.   SCIENCE

KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases

(2011) Chen Xie et al.   NUCLEIC ACIDS RESEARCH

Current chemotherapies for recurrent/metastatic head and neck cancer

(2010) Yann Molin et al.   ANTI-CANCER DRUGS

Expression Profiles and Clinical Correlations of Degradome Components in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma

(2010) A. Stokes et al.   CLINICAL CANCER RESEARCH

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

(2008) Johan Bussink et al.   LANCET ONCOLOGY